Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2311018
Max Phase: Preclinical
Molecular Formula: C52H54Br2N4O2
Molecular Weight: 767.03
Molecule Type: Small molecule
Associated Items:
ID: ALA2311018
Max Phase: Preclinical
Molecular Formula: C52H54Br2N4O2
Molecular Weight: 767.03
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C1=C2C[N@+]3(Cc4ccccc4)CC[C@]45c6ccccc6N6[C@@H]7OCC=C8C[N@+]9(Cc%10ccccc%10)CC[C@]%10%11c%12ccccc%12N([C@H](OC1)[C@@H]([C@H]64)[C@H]2C[C@@H]53)[C@H]%10[C@H]7[C@H]8C[C@@H]%119.[Br-].[Br-]
Standard InChI: InChI=1S/C52H54N4O2.2BrH/c1-3-11-33(12-4-1)29-55-23-21-51-39-15-7-9-17-41(39)53-47(51)45-37(27-43(51)55)35(31-55)19-25-57-49(45)54-42-18-10-8-16-40(42)52-22-24-56(30-34-13-5-2-6-14-34)32-36-20-26-58-50(53)46(48(52)54)38(36)28-44(52)56;;/h1-20,37-38,43-50H,21-32H2;2*1H/q+2;;/p-2/t37-,38-,43-,44-,45+,46+,47-,48-,49+,50+,51+,52+,55+,56+;;/m0../s1
Standard InChI Key: UGKVJJIXEUNOEA-ZAXHZHLMSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 767.03 | Molecular Weight (Monoisotopic): 766.4236 | AlogP: 7.70 | #Rotatable Bonds: 4 |
Polar Surface Area: 24.94 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -0.49 | CX LogD: -0.49 |
Aromatic Rings: 4 | Heavy Atoms: 58 | QED Weighted: 0.16 | Np Likeness Score: 1.07 |
1. Zlotos DP, Buller S, Tränkle C, Mohr K.. (2000) Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors., 10 (22): [PMID:11086722] [10.1016/s0960-894x(00)00509-6] |
Source(1):